DK168872B1 - Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden - Google Patents

Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden Download PDF

Info

Publication number: DK168872B1
Authority: DK; Denmark
Prior art keywords: type iii; procollagen; peptide; antibodies; amino
Prior art date: 1987-05-02

Application number

DK232988A

Other languages

Danish (da)

English (en)

Other versions

DK232988A (da

DK232988D0 (da

Inventor

Dietrich Brocks

Rupert Timpl

Original Assignee

Hoechst Ag

Max Planck Gesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-02

Filing date

1988-04-28

Publication date

1994-06-27

1988-04-28 Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag

1988-04-28 Publication of DK232988D0 publication Critical patent/DK232988D0/da

1988-11-03 Publication of DK232988A publication Critical patent/DK232988A/da

1994-06-27 Application granted granted Critical

1994-06-27 Publication of DK168872B1 publication Critical patent/DK168872B1/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 46
108010050808 Procollagen Proteins 0.000 title claims abstract description 43
238000000034 method Methods 0.000 title claims description 23
230000001900 immune effect Effects 0.000 title claims description 9
238000004519 manufacturing process Methods 0.000 title claims description 4
102000004169 proteins and genes Human genes 0.000 claims abstract description 10
108090000623 proteins and genes Proteins 0.000 claims abstract description 10
241001465754 Metazoa Species 0.000 claims abstract description 9
230000002163 immunogen Effects 0.000 claims abstract description 7
210000002966 serum Anatomy 0.000 claims description 11
241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
108060003552 hemocyanin Proteins 0.000 claims description 4
102000009027 Albumins Human genes 0.000 claims description 3
108010088751 Albumins Proteins 0.000 claims description 3
241000283707 Capra Species 0.000 claims description 3
108010039918 Polylysine Proteins 0.000 claims description 3
241000283984 Rodentia Species 0.000 claims description 3
229920000656 polylysine Polymers 0.000 claims description 3
241001494479 Pecora Species 0.000 claims 2
210000001124 body fluid Anatomy 0.000 abstract description 8
239000010839 body fluid Substances 0.000 abstract description 8
102000001187 Collagen Type III Human genes 0.000 abstract description 2
108010069502 Collagen Type III Proteins 0.000 abstract description 2
239000000427 antigen Substances 0.000 description 11
102000036639 antigens Human genes 0.000 description 11
108091007433 antigens Proteins 0.000 description 11
238000010790 dilution Methods 0.000 description 5
239000012895 dilution Substances 0.000 description 5
239000000047 product Substances 0.000 description 4
239000007857 degradation product Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000002649 immunization Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
238000003556 assay Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
238000000159 protein binding assay Methods 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 1
241000700198 Cavia Species 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
239000012506 Sephacryl® Substances 0.000 description 1
241000282887 Suidae Species 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
238000003271 compound fluorescence assay Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
230000003176 fibrotic effect Effects 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
229940027941 immunoglobulin g Drugs 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
HQXKKQDTQDYERH-UHFFFAOYSA-N n'-cyclohexyl-n-(2-morpholin-4-ylethyl)methanediimine;methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1.C1CCCCC1N=C=NCCN1CCOCC1 HQXKKQDTQDYERH-UHFFFAOYSA-N 0.000 description 1
108010033916 pN-collagen type III Proteins 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000028327 secretion Effects 0.000 description 1
241000894007 species Species 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Toxicology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Lifting Devices For Agricultural Implements (AREA)
Tires In General (AREA)
Agricultural Machines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK232988A 1987-05-02 1988-04-28 Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden DK168872B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3714634		1987-05-02
DE19873714634 DE3714634A1 (de)	1987-05-02	1987-05-02	Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung

Publications (3)

Publication Number	Publication Date
DK232988D0 DK232988D0 (da)	1988-04-28
DK232988A DK232988A (da)	1988-11-03
DK168872B1 true DK168872B1 (da)	1994-06-27

Family

ID=6326686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK232988A DK168872B1 (da)	1987-05-02	1988-04-28	Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden

Country Status (10)

Country	Link
EP (1)	EP0298210B1 (fi)
JP (1)	JPH0780913B2 (fi)
AT (1)	ATE98377T1 (fi)
DE (2)	DE3714634A1 (fi)
DK (1)	DK168872B1 (fi)
ES (1)	ES2061545T3 (fi)
FI (1)	FI95579C (fi)
IE (1)	IE63385B1 (fi)
NO (1)	NO175639C (fi)
PT (1)	PT87375B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6010862A (en) *	1987-11-06	2000-01-04	Washington Research Foundation	Methods of detecting collagen type III degradation in vivo
DE4225038C2 (de) *	1992-07-29	1995-11-30	Boehringer Mannheim Gmbh	Herstellung und Verwendung von Antikörpern gegen Kollagen
DK0711415T3 (da) *	1993-07-28	1999-04-26	Roche Diagnostics Gmbh	Immunoanalyse til påvisning af collagen eller collagenfragmenter
GB9506050D0 (en)	1995-03-24	1995-05-10	Osteometer A S	Assaying collagen fragments in body fluids
ATE199185T1 (de)	1994-10-17	2001-02-15	Osteometer Biotech As	Einschätzung der fragmentierungsmuster von kollagen in körperflüssigkeiten und diagnose von mit dem kollagenmetabolismus zusammenhängenden störungen
US6107047A (en) *	1996-03-21	2000-08-22	Osteometer Biotech A/S	Assaying protein fragments in body fluids
GB9617616D0 (en)	1996-08-22	1996-10-02	Osteometer Biotech As	Assaying protein fragments in body fluids
US6660481B2 (en)	1996-12-09	2003-12-09	Osteometer Biotech A/S	Sandwich assays for collagen type I fragments
US6117646A (en) *	1997-09-22	2000-09-12	Osteometer Biotech A/S	Assaying protein fragments in body fluids
US7541149B1 (en)	1998-05-28	2009-06-02	Siemens Healthcare Diagnostics, Inc.	Monoclonal antibody and assay for detecting PIIINP
US6602980B1 (en)	1998-06-19	2003-08-05	Washington Research Foundation	Collagen type III synthetic peptides for collagen resorption assays
US6916903B2 (en)	1998-06-19	2005-07-12	Washington Research Foundation	Collagen type III synthetic peptides for collagen resorption assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2816841A1 (de) *	1978-04-18	1979-10-31	Max Planck Gesellschaft	Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
DE3209149A1 (de) *	1982-03-13	1983-10-06	Hoechst Ag	Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum

1987
- 1987-05-02 DE DE19873714634 patent/DE3714634A1/de not_active Withdrawn
1988
- 1988-04-27 DE DE88106747T patent/DE3886109D1/de not_active Expired - Fee Related
- 1988-04-27 AT AT88106747T patent/ATE98377T1/de not_active IP Right Cessation
- 1988-04-27 ES ES88106747T patent/ES2061545T3/es not_active Expired - Lifetime
- 1988-04-27 EP EP88106747A patent/EP0298210B1/de not_active Expired - Lifetime
- 1988-04-28 JP JP63104474A patent/JPH0780913B2/ja not_active Expired - Lifetime
- 1988-04-28 DK DK232988A patent/DK168872B1/da not_active IP Right Cessation
- 1988-04-29 IE IE128988A patent/IE63385B1/en not_active IP Right Cessation
- 1988-04-29 NO NO881904A patent/NO175639C/no not_active IP Right Cessation
- 1988-04-29 PT PT87375A patent/PT87375B/pt active IP Right Grant
- 1988-04-29 FI FI882018A patent/FI95579C/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE63385B1 (en)	1995-04-19
NO881904L (no)	1988-11-03
NO881904D0 (no)	1988-04-29
FI882018A0 (fi)	1988-04-29
EP0298210A2 (de)	1989-01-11
FI882018A (fi)	1988-11-03
NO175639C (no)	1994-11-09
JPS63292061A (ja)	1988-11-29
PT87375B (pt)	1992-08-31
EP0298210B1 (de)	1993-12-08
EP0298210A3 (de)	1991-05-15
DK232988A (da)	1988-11-03
JPH0780913B2 (ja)	1995-08-30
IE881289L (en)	1988-11-02
DE3886109D1 (de)	1994-01-20
DK232988D0 (da)	1988-04-28
NO175639B (fi)	1994-08-01
FI95579C (fi)	1996-02-26
DE3714634A1 (de)	1988-11-17
ATE98377T1 (de)	1993-12-15
ES2061545T3 (es)	1994-12-16
PT87375A (pt)	1989-05-31
FI95579B (fi)	1995-11-15

Legal Events

Date	Code	Title	Description
1994-06-27	B1	Patent granted (law 1993)
2002-12-02	PBP	Patent lapsed

Publication	Publication Date	Title
Clark et al.	1982	Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties.
Flanders et al.	1988	Antibodies to peptide determinants in transforming growth factor. beta. and their applications
EP0864865B1 (en)	2001-08-22	Method for measuring glycated hemoglobin
Nowack et al.	1975	Specificity of the antibody response in inbred mice to bovine type I and type II collagen.
US4264571A (en)	1981-04-28	Radioimmunoassay of thymosin α1
JPH0588421B2 (fi)	1993-12-22
EP2105447A1 (en)	2009-09-30	Avian-derived antibody capable of binding specifically to human hmgb1, immunological determination method for human hmgb1, and immunological determination reagent for human hmgb1
DK168872B1 (da)	1994-06-27	Fremgangsmåde til fremstilling af antistoffer til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III), antistoffer fremstillet ved fremgangsmåden, anvendelsen af antistofferne til immunologisk bestemmelse af aminoterminalt prokollagen peptid (type III) og/eller prokollagen (type III) og udgangsprodukt til brug ved fremgangsmåden
Mercham et al.	1982	[42] Antibodies to insoluble and solubilized elastin
US4339427A (en)	1982-07-13	Radioimmunoassay of thymosinα
US4124700A (en)	1978-11-07	Immunoassay for thymopoietin
DK169571B1 (da)	1994-12-05	Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåder til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof
Graindorge et al.	1978	Radioimmunologic method for detection of antitubular basement membrane antibodies
AU715797B2 (en)	2000-02-10	Methods for determining the presence of brain protein S-100
CA2174559C (en)	2010-10-19	Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it
US5679583A (en)	1997-10-21	Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
FI96433B (fi)	1996-03-15	Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
Potter et al.	1986	Identification of an antigenic determinant within the phylogenetically conserved triprolyl region of myelin basic protein.
Erhard et al.	1994	Identification of antigenic differences of recombinant and pituitary bovine growth hormone using monoclonal antibodies
Marchalonis et al.	1977	Lymphocyte surface immunoglobulins: Evolutionary origins and involvement in activation
Ruoslahti et al.	1977	Antigenic differences in nuclear proteins of normal liver and hepatoma
Motte et al.	1987	A two-site immunoradiometric assay for serum calcitonin using monoclonal anti-peptide antibodies
Ikeyama et al.	1984	Radioimmunoassay of serum thymic factor (FTS)
US20030158391A1 (en)	2003-08-21	Anitbodies and method for producing same, the use thereof and immunisation cocktails, immunoassays-sets and peptides
Young et al.	1981	Genetic control of the immune response to myoglobin. VII. Antibody responses to myoglobin variants reveal that gene restriction of the antibody responses to myoglobin antigenic sites is dependent on the chemical properties of the sites